CARBOGEN AMCIS Names Mark C Griffiths Chief E - News, Search Jobs .

BUBENDORF, Switzerland (July 12, 2011)Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announced that Mark C. Griffiths has been named chief executive officer, effective today. In his new role, Griffiths will take responsibility for the CARBOGEN AMCIS Swiss business and will describe to Jay Vyas, managing director of Dishman Pharmaceuticals and Chemicals Ltd.

CARBOGEN AMCIS parent company.

Mark C. Griffiths has been associated with CARBOGEN AMCIS as manager of operations and chief executive officer for about ten years. Most recently, he has been running for the Dishman Group as operations advisor overseeing the figure and expression of the groups large-scale manufacturing facilities for commercial supply of Highly Potent APIs (HPAPIs) in Shanghai, China, and Ahmedabad, India.

We are delighted that Mark agreed to join CARBOGEN AMCIS as chief executive officer, commented Jay Vyas. Marks industrial expertise and proven track disk in the pharmaceutical industry make him the ideal executive to lead CARBOGEN AMCIS growth. We are positive in Marks ability to quicken the winner of our society and our customers by maintaining the stress on high performance.

Griffiths has over 28 days of relevant industrial experience delivering high added value technical and operational solutions within the pharmaceutical and fine chemical industry. Qualified as an engineer and having gained important experience in the direction of complex, multi-task, multi-input projects, he brings a cross-functional ability to call and optimize technical, operational and management issues. Griffiths has designed, built and managed facilities ranging in use from search and growing to manufacturing. Griffiths holds a Chief of Science in engineering from Bristol University, UK.

CARBOGEN AMCIS AG is a lead service provider, offering a portfolio of drug-development and commercialization services to the pharmaceutical and biopharmaceutical industry at all stages of drug development. The integrated services provide innovative chemistry solutions to support timely and safe drug development allowing customers to take the better use of available resources. CARBOGEN AMCIS AG is owned by Dishman Pharmaceuticals and Chemicals Ltd. Ahmedabad, India.

Dishman Group (www.dishmangroup.com) is a global outsourcing partner for the pharmaceutical industry, offering a portfolio of development, scale-up and commercial API manufacturing services. Dishman Group improves its customers businesses by providing a rate of growth and manufacturing solutions at locations in Europe, China and India.